Icagen, Inc. To Present At The Biotechnology Industry Organization (BIO) CEO & Investor Conference

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Feb. 8, 2006--Icagen, Inc. (NASDAQ: ICGN) today announced that P. Kay Wagoner, Ph.D., Chief Executive Officer, will present at the BIO CEO & Investor Conference at the Waldorf-Astoria Hotel in New York City on Wednesday February 15th at 11:30 a.m. ET.

Back to news